by Inception Point AI
Dr. Ben Synth explores what clinical trials and real-world data reveal about stopping Ozempic and similar GLP-1 medications. From understanding why most patients regain significant weight to the biological mechanisms driving rebound effects, this series examines the science behind discontinuation and whether these drugs require lifelong use. For more content like this, visit QuietPlease.ai This content was created in partnership and with the help of Artificial Intelligence AI.
Language
🇺🇲
Publishing Since
4/7/2026
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
April 7, 2026
Join Dr. Ben Synth as he explores what really happens when you stop taking Ozempic—the rebound effect, metabolic changes, and clinical trial contradictions most doctors don't explain. Discover why your body fights back after stopping GLP-1 medications and whether these weight loss drugs require lifelong commitment. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.
April 7, 2026
Ben Synth explores whether Ozempic must be taken indefinitely, analyzing clinical trials showing two-thirds weight regain after stopping, real-world data revealing varied outcomes, and the biological mechanisms behind rebound effects. He examines transition strategies, resistance training benefits, and the gap between medical need and system support in managing GLP-1 discontinuation. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.
April 7, 2026
Ben Synth examines the biological mechanisms behind weight regain after stopping Ozempic, exploring why the body fights back so aggressively. From muscle loss and metabolic changes to hunger signals and evolutionary survival programming, this episode covers the science showing that two-thirds of lost weight typically returns within a year of discontinuation. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
Dr. Ben Synth explores what clinical trials and real-world data reveal about stopping Ozempic and similar GLP-1 medications. From understanding why most patients regain significant weight to the biological mechanisms driving rebound effects, this series examines the science behind discontinuation and whether these drugs require lifelong use.
For more content like this, visit QuietPlease.ai
This content was created in partnership and with the help of Artificial Intelligence AI.
This podcast updates daily.
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
No, this podcast does not typically feature guests.
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.